249 related articles for article (PubMed ID: 11601892)
1. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus.
Meng J; Dai X; Chang JC; Lopareva E; Pillot J; Fields HA; Khudyakov YE
Virology; 2001 Sep; 288(2):203-11. PubMed ID: 11601892
[TBL] [Abstract][Full Text] [Related]
2. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources.
Meng J; Pillot J; Dai X; Fields HA; Khudyakov YE
Virology; 1998 Sep; 249(2):316-24. PubMed ID: 9791023
[TBL] [Abstract][Full Text] [Related]
4. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2004 Jun; 22(20):2578-85. PubMed ID: 15193383
[TBL] [Abstract][Full Text] [Related]
5. [Identification of a novel antigenic epitope on GST fusion-expressed and ORF2-encoded proteins of hepatitis E virus].
Liang JH; Liang LM; Dong M; Han ZG; Dong C; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):321-3, 327. PubMed ID: 18394332
[TBL] [Abstract][Full Text] [Related]
6. Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.
Yang S; Wang C; Fang X; Zhai L; Dong C; Ding L; Meng J; Wang L
Virus Res; 2010 Aug; 151(2):162-9. PubMed ID: 20451569
[TBL] [Abstract][Full Text] [Related]
7. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.
Zhang H; Dai X; Shan X; Meng J
Virus Res; 2009 Jun; 142(1-2):140-3. PubMed ID: 19428747
[TBL] [Abstract][Full Text] [Related]
8. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle].
Dong C; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795
[TBL] [Abstract][Full Text] [Related]
9. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system.
Takahashi M; Hoshino Y; Tanaka T; Takahashi H; Nishizawa T; Okamoto H
Arch Virol; 2008; 153(4):657-66. PubMed ID: 18266052
[TBL] [Abstract][Full Text] [Related]
10. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.
Zhang J; Gu Y; Ge SX; Li SW; He ZQ; Huang GY; Zhuang H; Ng MH; Xia NS
Vaccine; 2005 Apr; 23(22):2881-92. PubMed ID: 15780737
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
[TBL] [Abstract][Full Text] [Related]
15. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
Schofield DJ; Glamann J; Emerson SU; Purcell RH
J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
[TBL] [Abstract][Full Text] [Related]
18. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.
Niikura M; Takamura S; Kim G; Kawai S; Saijo M; Morikawa S; Kurane I; Li TC; Takeda N; Yasutomi Y
Virology; 2002 Feb; 293(2):273-80. PubMed ID: 11886247
[TBL] [Abstract][Full Text] [Related]
19. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
[TBL] [Abstract][Full Text] [Related]
20. Role of asparagine at position 562 in dimerization and immunogenicity of the hepatitis E virus capsid protein.
Xu M; Behloul N; Wen J; Zhang J; Meng J
Infect Genet Evol; 2016 Jan; 37():99-107. PubMed ID: 26584510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
